Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary
Daeun Ryu1,2,3, Seok Jin Kim4, Yourae Hong1
1Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
Purpose:
In multiple myeloma, extramedullary progression is associated with treatment resistance and a high mortality rate. To understand the molecular mechanisms controlling the devastating progression of myeloma, we applied single-cell RNA-sequencing (RNA-seq) to myeloma in the bone marrow and myelomatous pleural effusions or ascites.
Experimental Design:
Bone marrow or extramedullary myeloma samples were collected from 15 patients and subjected to single-cell RNA-seq. The single-cell transcriptome data of malignant plasma cells and the surrounding immune microenvironment were analyzed.
Results:
Comparisons of single-cell transcriptomes revealed the systematic activation of proliferation, antigen presentation, proteasomes, glycolysis, and oxidative phosphorylation pathways in extramedullary myeloma cells. The myeloma cells expressed multiple combinations of growth factors and receptors, suggesting autonomous and pleiotropic growth potential at the single-cell level. Comparisons of the tumor microenvironment revealed the presence of cytotoxic T lymphocytes and natural killer (NK) cells in both the bone marrow and extramedullary ascites, demonstrating a gene-expression phenotype indicative of functional compromise. In parallel, isolated myeloma cells persistently expressed class I MHC molecules and upregulated inhibitory molecules for cytotoxic T and NK cells.
Conclusions:
These data suggest that myeloma cells are equipped with specialized immune evasion mechanisms in cytotoxic microenvironments. Taken together, single-cell transcriptome analysis revealed transcriptional programs associated with aggressive myeloma progression that support autonomous cell proliferation and immune evasion.
Insights
Single-cell RNA sequencing reveals that extramedullary multiple myeloma cells exhibit enhanced proliferation and immune evasion mechanisms. These findings in myeloma progression highlight potential therapeutic targets for treatment resistance.
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Extramedullary progression in multiple myeloma is linked to treatment resistance and poor prognosis.
- Understanding the molecular drivers of myeloma progression is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the molecular mechanisms underlying extramedullary multiple myeloma progression.
- To compare the transcriptomes of myeloma cells in the bone marrow versus extramedullary sites using single-cell RNA sequencing.
Main Methods:
- Single-cell RNA sequencing (RNA-seq) was performed on bone marrow and extramedullary myeloma samples from 15 patients.
- Transcriptome data from malignant plasma cells and the immune microenvironment were analyzed.
Main Results:
- Extramedullary myeloma cells showed activated pathways for proliferation, antigen presentation, proteasomes, glycolysis, and oxidative phosphorylation.
- Myeloma cells displayed autonomous growth potential and expressed immune evasion molecules, including upregulated inhibitory receptors for cytotoxic T and NK cells.
- The tumor microenvironment contained functionally compromised cytotoxic T lymphocytes and natural killer (NK) cells.
Conclusions:
- Multiple myeloma cells possess specialized immune evasion strategies within cytotoxic microenvironments.
- Single-cell transcriptome analysis identified transcriptional programs driving aggressive myeloma progression, supporting autonomous proliferation and immune evasion.
Related Concept Videos
The Tumor Microenvironment
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Differentiation of Common Myeloid Progenitor Cells
Somatic to iPS Cell Reprogramming
Epigenetic Regulation
X-chromosome...

